Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperBartolomé R. Celli, Richard ZuWallack, Ruben Pauwels et al.|European Respiratory Journal|2004Cited by 4.4k
Independent Relationship of Left Atrial Size and Mortality in Patients with Heart Failure: An Individual Patient Meta-Analysis of Longitudinal Data (MeRGE Heart Failure)Andrea Rossi, Gillian Whalley, Pier Luigi Temporelli et al.|European Journal of Heart Failure|2009Cited by 168
Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With LymphomaCorrado Tarella, Alessandro Rambaldi, Roberto Passera et al.|Journal of Clinical Oncology|2010Cited by 167
The lymphocyte to monocyte ratio improves the IPI‐risk definition of diffuse large B‐cell lymphoma when rituximab is added to chemotherapyAlessandro Rambaldi, Corrado Tarella, Cristina Boschini et al.|American Journal of Hematology|2013Cited by 65
Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter StudyDino Amadori, Annalisa Volpi, Oriana Nanni et al.|Journal of Clinical Oncology|2000Cited by 58